Researchers from Virginia Commonwealth University and Virginia Tech have developed a molecule that could be used to help diagnose as well as treat brain tumors. One of the most deadly and common brain tumors, glioblastoma, is difficult to visualize using standard imaging modalities. By simultaneously imaging and attacking the tumor cells, the compound could delay or avert a relapse of the tumor. The researchers demonstrated in an animal study that a nanoparticle, when used with an MRI contrast agent, could facilitate imaging of the brain tumor while also providing radiation therapy.
